Total Payments
$22,529
2024 Payments
$438.16
Companies
43
Transactions
373
Medicare Patients
14,621
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$10,085 (44.8%)
Food & Beverage$7,020 (31.2%)
Travel$2,615 (11.6%)
Consulting$2,335 (10.4%)
Education$473.69 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,025 | 4 | 40.1% |
| Food and Beverage | $7,020 | 341 | 31.2% |
| Travel and Lodging | $2,615 | 12 | 11.6% |
| Consulting Fee | $2,335 | 2 | 10.4% |
| Honoraria | $1,060 | 1 | 4.7% |
| Education | $473.69 | 13 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $11,729 | 39 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $3,788 | 18 | $0 (2022) |
| Janssen Biotech, Inc. | $1,402 | 20 | $0 (2023) |
| Astellas Pharma US Inc | $935.86 | 54 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $727.10 | 35 | $0 (2024) |
| PFIZER INC. | $614.52 | 53 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $345.17 | 18 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $292.19 | 10 | $0 (2023) |
| ABBVIE INC. | $189.63 | 17 | $0 (2024) |
| Teleflex LLC | $184.54 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.16 | 16 | Dendreon Pharmaceuticals LLC ($130.27) |
| 2023 | $969.83 | 34 | Myriad Genetic Laboratories, Inc. ($151.24) |
| 2022 | $4,078 | 34 | TOLMAR Pharmaceuticals, Inc. ($2,563) |
| 2021 | $1,418 | 18 | TOLMAR Pharmaceuticals, Inc. ($1,078) |
| 2020 | $7,495 | 25 | Ferring Pharmaceuticals Inc. ($7,350) |
| 2019 | $5,361 | 84 | Ferring Pharmaceuticals Inc. ($4,280) |
| 2018 | $1,077 | 72 | PFIZER INC. ($334.85) |
| 2017 | $1,692 | 90 | Astellas Pharma US Inc ($307.55) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $89.59 | General |
| Category: Urology | ||||||
| 07/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: UROLOGY | ||||||
| 05/21/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Immunotherapy | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Oncology | ||||||
| 04/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/28/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: HORMONE THERAPY | ||||||
| 03/19/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 01/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LENVIMA | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 01/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/16/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/29/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Oncology | ||||||
| 10/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/12/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/27/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $46.37 | General |
| Category: rezum_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,156 | 4,383 | $474,693 | $205,181 |
| 2022 | 47 | 3,990 | 6,482 | $606,778 | $290,035 |
| 2021 | 48 | 3,948 | 6,832 | $595,655 | $296,379 |
| 2020 | 46 | 3,527 | 5,002 | $503,551 | $212,014 |
Total Patients
14,621
Total Services
22,699
Medicare Billing
$1.0M
Procedure Codes
174
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 680 | 1,001 | $144,695 | $92,101 | 63.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 120 | $84,000 | $16,107 | 19.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 75 | 82 | $33,400 | $16,073 | 48.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 38 | 39 | $22,425 | $11,006 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $21,825 | $10,905 | 50.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 132 | 239 | $33,616 | $9,398 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 63 | $10,395 | $6,749 | 64.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 80 | 99 | $9,900 | $6,501 | 65.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 275 | 329 | $11,515 | $5,929 | 51.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 380 | 482 | $14,460 | $3,843 | 26.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 33 | 33 | $9,900 | $3,423 | 34.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 28 | 28 | $14,000 | $3,048 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 38 | $3,940 | $2,753 | 69.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 58 | $4,060 | $2,694 | 66.4% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 127 | 138 | $5,244 | $2,487 | 47.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 713 | 1,065 | $6,390 | $2,330 | 36.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 14 | 16 | $14,400 | $1,622 | 11.3% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 34 | 45 | $2,025 | $1,138 | 56.2% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 12 | 17 | $2,975 | $1,073 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,595 | $1,026 | 64.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 23 | 39 | $4,378 | $798.65 | 18.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,100 | $744.10 | 67.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 54 | 68 | $7,140 | $563.72 | 7.9% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 15 | 17 | $765.00 | $465.46 | 60.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 33 | $924.00 | $357.75 | 38.7% |
About Dr. Michael Lutz, MD
Dr. Michael Lutz, MD is a Urology healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326020157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lutz, MD has received a total of $22,529 in payments from pharmaceutical and medical device companies, with $438.16 received in 2024. These payments were reported across 373 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,025).
As a Medicare-enrolled provider, Lutz has provided services to 14,621 Medicare beneficiaries, totaling 22,699 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Rochester Hills, MI
- Active Since 11/17/2005
- Last Updated 03/28/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1326020157
Products in Payments
- NOCDURNA (Drug) $11,255
- ELIGARD (Drug) $3,788
- ERLEADA (Drug) $1,114
- PROVENGE (Drug) $887.98
- XTANDI (Drug) $504.26
- FIRMAGON (Drug) $483.05
- XIAFLEX (Biological) $345.17
- MYRBETRIQ (Drug) $265.01
- ZYTIGA (Drug) $252.20
- Myrbetriq (Drug) $213.36
- Erleada (Drug) $201.46
- YONSA (Drug) $160.73
- PROLARIS (Device) $151.24
- Nubeqa (Drug) $146.59
- Xofigo (Drug) $145.60
- UROLIFT (Device) $136.50
- Androgel (Drug) $133.73
- Axumin (Drug) $129.77
- TOVIAZ (Drug) $127.85
- Xtandi (Drug) $119.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.